The risk or severity of adverse effects can be increased when Lormetazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when nimodipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with felbamate.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when buspirone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when carvedilol is combined with captopril.


The risk or severity of adverse effects can be increased when isoflurane is combined with Phenelzine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with flunarizine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Cariprazine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when procaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when prazosin is combined with Bretylium.


The risk or severity of adverse effects can be increased when triflupromazine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when felbamate is combined with duloxetine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when butabarbital is combined with carbamazepine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when isoflurane is combined with Lofexidine.


The risk or severity of adverse effects can be increased when triazolam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Tolcapone.


The risk or severity of adverse effects can be increased when temazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when zopiclone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with clonazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with topiramate.


The risk or severity of adverse effects can be increased when tetracaine is combined with butamben.


The risk or severity of adverse effects can be increased when clozapine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when olanzapine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when pergolide is combined with vincristine.


The risk or severity of adverse effects can be increased when nimesulide is combined with salicylamide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ketorolac is combined with Salsalate.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Etomidate is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when trandolapril is combined with leflunomide.


The risk or severity of adverse effects can be increased when ketorolac is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when alprostadil is combined with aspirin.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Echothiophate.


The risk or severity of adverse effects can be increased when butorphanol is combined with Pirlindole.


The risk or severity of adverse effects can be increased when butorphanol is combined with Toloxatone.


The risk or severity of adverse effects can be increased when Clodronic Acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with dipyridamole.


The risk or severity of adverse effects can be increased when diflunisal is combined with haloperidol.


The risk or severity of adverse effects can be increased when etizolam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Tixocortol is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Vecuronium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when mepivacaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when trimetrexate is combined with gabapentin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when etizolam is combined with imipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when valsartan is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when midazolam is combined with clonidine.


The risk or severity of adverse effects can be increased when valsartan is combined with felodipine.


The risk or severity of adverse effects can be increased when Fosamprenavir is combined with meperidine.


The risk or severity of adverse effects can be increased when etizolam is combined with loratadine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with epirizole.


The risk or severity of adverse effects can be increased when captopril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when captopril is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when nystatin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when glutethimide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when halothane is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when halothane is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Apremilast is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with clidinium.


The risk or severity of adverse effects can be increased when propantheline is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ramipril.


The risk or severity of adverse effects can be increased when fenbufen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Droxicam is combined with Propacetamol.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with meclizine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when estazolam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when bupivacaine is combined with valsartan.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ketorolac.


The risk or severity of adverse effects can be increased when propofol is combined with metolazone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nabumetone.


The risk or severity of adverse effects can be increased when Metixene is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Toloxatone is combined with ritodrine.


The risk or severity of adverse effects can be increased when carboprost trometamol is combined with Prostaglandin E2.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ramipril is combined with chloroquine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with methscopolamine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with doxepin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when amisulpride is combined with carisoprodol.


The risk or severity of adverse effects can be increased when amisulpride is combined with sulpiride.


The risk or severity of adverse effects can be increased when Ephedrine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with procaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when maprotiline is combined with levodopa.


The risk or severity of adverse effects can be increased when maprotiline is combined with metoclopramide.


The risk or severity of adverse effects can be increased when brotizolam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with pimozide.


The risk or severity of adverse effects can be increased when bromazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with niflumic acid.


The risk or severity of adverse effects can be increased when zopiclone is combined with levodopa.


The risk or severity of adverse effects can be increased when dipyridamole is combined with mesalamine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with levodopa.


The risk or severity of adverse effects can be increased when carboprost trometamol is combined with misoprostol.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Bretylium.


The risk or severity of adverse effects can be increased when propofol is combined with cilazapril.


The risk or severity of adverse effects can be increased when salicylic acid is combined with methazolamide.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Agomelatine.


The risk or severity of adverse effects can be increased when metaraminol is combined with clenbuterol.


The risk or severity of adverse effects can be increased when benazepril is combined with azelastine.


The risk or severity of adverse effects can be increased when Tramadol is combined with theobromine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Mirabegron.


The risk or severity of adverse effects can be increased when clomipramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when nicergoline is combined with pilocarpine.


The risk or severity of adverse effects can be increased when quinapril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when temazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when triprolidine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when nicergoline is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when codeine is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when indapamide is combined with terazosin.


The risk or severity of adverse effects can be increased when dapsone is combined with butalbital.


The risk or severity of adverse effects can be increased when Phenelzine is combined with olanzapine.


The risk or severity of adverse effects can be increased when Apremilast is combined with medrysone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with methadone.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when sulindac is combined with prednisone.


The risk or severity of adverse effects can be increased when Desloratadine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with dyclonine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when lithium ion is combined with Agomelatine.


The risk or severity of adverse effects can be increased when quetiapine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when losartan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with methazolamide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with butalbital.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when ketamine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with venlafaxine.


The risk or severity of adverse effects can be increased when etodolac is combined with alclofenac.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with lidocaine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with clemastine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with sertraline.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when estazolam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when estazolam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when tolterodine is combined with Metixene.


The risk or severity of adverse effects can be increased when dyclonine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with fexofenadine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when efavirenz is combined with nevirapine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with quetiapine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Perospirone.


The risk or severity of adverse effects can be increased when rescinnamine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when trimipramine is combined with citalopram.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Ephedrine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when quinidine is combined with levorphanol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when carvedilol is combined with quetiapine.


The risk or severity of adverse effects can be increased when EDOXABAN is combined with meperidine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Cariprazine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with flunarizine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when procyclidine is combined with tolterodine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Apremilast is combined with loteprednol.


The risk or severity of adverse effects can be increased when meprobamate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when oxazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with diclofenac.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when miconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when eperisone is combined with pravastatin.


The risk or severity of adverse effects can be increased when sotalol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when sotalol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when oxybutynin is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when baclofen is combined with tizanidine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with prazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with oxprenolol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when meclizine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with oxprenolol.


The risk or severity of adverse effects can be increased when secobarbital is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with antipyrine.


The risk or severity of adverse effects can be increased when pimozide is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when benzocaine is combined with prilocaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with fosinopril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with doxepin.


The risk or severity of adverse effects can be increased when Agomelatine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with levorphanol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with tizanidine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when prazosin is combined with benazepril.


The risk or severity of adverse effects can be increased when thiamylal is combined with Difenoxin.


The risk or severity of adverse effects can be increased when salicylamide is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when paroxetine is combined with amoxapine.


The risk or severity of adverse effects can be increased when paroxetine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when scopolamine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when baclofen is combined with cetirizine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when baclofen is combined with protriptyline.


The risk or severity of adverse effects can be increased when furosemide is combined with Arbekacin.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with citalopram.


The risk or severity of adverse effects can be increased when rapamycin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when trimipramine is combined with procarbazine.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with ramipril.


The risk or severity of adverse effects can be increased when Ximelagatran is combined with meperidine.


The risk or severity of adverse effects can be increased when quetiapine is combined with cilazapril.


The risk or severity of adverse effects can be increased when Butethal is combined with etizolam.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with duloxetine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when indomethacin is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with terazosin.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with promethazine.


The risk or severity of adverse effects can be increased when selegiline is combined with Iloperidone.


The risk or severity of adverse effects can be increased when indomethacin is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when celecoxib is combined with flumethasone.


The risk or severity of adverse effects can be increased when docetaxel is combined with Trabectedin.


The risk or severity of adverse effects can be increased when enalapril is combined with meperidine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when chlormezanone is combined with topiramate.


The risk or severity of adverse effects can be increased when Butethal is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when scopolamine is combined with clonazepam.


The risk or severity of adverse effects can be increased when scopolamine is combined with promethazine.


The risk or severity of adverse effects can be increased when topiramate is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with tiapride.


The risk or severity of adverse effects can be increased when dexamethasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when aspirin is combined with difluprednate.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with topiramate.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when thiothixene is combined with enflurane.


The risk or severity of adverse effects can be increased when ethopropazine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with thiothixene.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when diazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Tolcapone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Tramadol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when baclofen is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when baclofen is combined with flunarizine.


The risk or severity of adverse effects can be increased when mesalamine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when lorazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when clozapine is combined with ramipril.


The risk or severity of adverse effects can be increased when salicylic acid is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when lorazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nicardipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Etomidate is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when olanzapine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with diltiazem.


The risk or severity of adverse effects can be increased when trazodone is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when zopiclone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Perospirone is combined with etizolam.


The risk or severity of adverse effects can be increased when zopiclone is combined with triprolidine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with doxorubicin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with scopolamine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ketamine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with quetiapine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when methadone is combined with protriptyline.


The risk or severity of adverse effects can be increased when imipramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when methadone is combined with cetirizine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when cocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when pentazocine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with thiamylal.


The risk or severity of adverse effects can be increased when methadone is combined with glutethimide.


The risk or severity of adverse effects can be increased when pimozide is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when procarbazine is combined with risperidone.


The risk or severity of adverse effects can be increased when methadone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when procarbazine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Propacetamol is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when morphine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Propacetamol is combined with paramethasone.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with physostigmine.


The risk or severity of adverse effects can be increased when benzoic acid is combined with barnidipine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methadone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Clevidipine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Spirapril is combined with floctafenine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with alprazolam.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nisoldipine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with loxapine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Mometasone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with terazosin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with imipramine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when oxprenolol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nimesulide is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with metolazone.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Clofarabine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Carbetocin is combined with prazosin.


The risk or severity of adverse effects can be increased when venlafaxine is combined with zotepine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Tapentadol is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with propranolol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Carbetocin is combined with imipramine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Iloperidone.


The risk or severity of adverse effects can be increased when paramethasone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when sotalol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Naftifine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when bumetanide is combined with penbutolol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with tizanidine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when nicardipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when lisinopril is combined with nimesulide.


The risk or severity of adverse effects can be increased when nortriptyline is combined with metaproterenol.


The risk or severity of adverse effects can be increased when celecoxib is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Asenapine.


The risk or severity of adverse effects can be increased when efavirenz is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nitrazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when docetaxel is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Remoxipride is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with nabumetone.


The risk or severity of adverse effects can be increased when reserpine is combined with desipramine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with clonidine.


The risk or severity of adverse effects can be increased when reserpine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Amrinone.


The risk or severity of adverse effects can be increased when promethazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when methysergide is combined with Bortezomib.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when resveratrol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when buspirone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when quinapril is combined with chloroquine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with amisulpride.


The risk or severity of adverse effects can be increased when quinapril is combined with sulindac.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Tapentadol is combined with rasagiline.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Salmeterol.


The risk or severity of adverse effects can be increased when Pirlindole is combined with maprotiline.


The risk or severity of adverse effects can be increased when antipyrine is combined with epirizole.


The risk or severity of adverse effects can be increased when promazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with enalapril.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when furazolidone is combined with hydromorphone.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Benidipine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when procaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Aliskiren.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with HEROIN.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with acetylcholine.


The risk or severity of adverse effects can be increased when lorazepam is combined with meprobamate.


The risk or severity of adverse effects can be increased when estazolam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when glutethimide is combined with Perospirone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with zonisamide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Clevidipine.


The risk or severity of adverse effects can be increased when methysergide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when clidinium is combined with doxepin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with furosemide.


The risk or severity of adverse effects can be increased when Arotinolol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nitric oxide.


The risk or severity of adverse effects can be increased when haloperidol is combined with procaine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with atenolol.


The risk or severity of adverse effects can be increased when Propacetamol is combined with acemetacin.


The risk or severity of adverse effects can be increased when temazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when diazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when diazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when minoxidil is combined with tizanidine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with quinapril.


The risk or severity of adverse effects can be increased when Bortezomib is combined with bumetanide.


The risk or severity of adverse effects can be increased when haloperidol is combined with HEROIN.


The risk or severity of adverse effects can be increased when minoxidil is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with promethazine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when bromocriptine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when levodopa is combined with Pirlindole.


The risk or severity of adverse effects can be increased when bromocriptine is combined with acetaminophen.


The risk or severity of adverse effects can be increased when alprazolam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with efavirenz.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Linagliptin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when labetalol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when midodrine is combined with phenylephrine.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when triamcinolone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Telmisartan.


The risk or severity of adverse effects can be increased when diflunisal is combined with flumethasone.


The risk or severity of adverse effects can be increased when clonidine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when olanzapine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when dapsone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with malathion.


The risk or severity of adverse effects can be increased when amphotericin b is combined with methyldopa.


The risk or severity of adverse effects can be increased when thalidomide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with phenylephrine.


The risk or severity of adverse effects can be increased when carprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when butalbital is combined with levodopa.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when prilocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when clidinium is combined with promethazine.


The risk or severity of adverse effects can be increased when clidinium is combined with clonazepam.


The risk or severity of adverse effects can be increased when losartan is combined with rescinnamine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when antipyrine is combined with halcinonide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ramipril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when levorphanol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with secobarbital.


The risk or severity of adverse effects can be increased when pentazocine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when lorazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when efavirenz is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when losartan is combined with enalapril.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with equilin.


The risk or severity of adverse effects can be increased when Voriconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Articaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when nabumetone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when procaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when procaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when zaleplon is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when nabumetone is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when phenylephrine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with cinoxacin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Spirapril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when ethanol is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Paliperidone is combined with flunarizine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when Halobetasol is combined with galanthamine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with vinblastine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Olopatadine is combined with formestane.


The risk or severity of adverse effects can be increased when prazosin is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when morphine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when morphine is combined with polythiazide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with trazodone.


The risk or severity of adverse effects can be increased when azelastine is combined with epirizole.


The risk or severity of adverse effects can be increased when naratriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with dipyridamole.


The risk or severity of adverse effects can be increased when oxazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Lurasidone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with periciazine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with paramethasone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with benazepril.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Eprosartan.


The risk or severity of adverse effects can be increased when benztropine is combined with topiramate.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Clobetasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when hexetidine is combined with manidipine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when triamterene is combined with Nebivolol.


The risk or severity of adverse effects can be increased when ibuprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when Articaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when phenylephrine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with Calcifediol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Flibanserin.


The risk or severity of adverse effects can be increased when phenytoin is combined with scopolamine.


The risk or severity of adverse effects can be increased when trandolapril is combined with suprofen.


The risk or severity of adverse effects can be increased when chlormezanone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when trandolapril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with butalbital.


The risk or severity of adverse effects can be increased when thalidomide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when HEROIN is combined with theobromine.


The risk or severity of adverse effects can be increased when codeine is combined with diazepam.


The risk or severity of adverse effects can be increased when thiamylal is combined with tiagabine.


The risk or severity of adverse effects can be increased when ethanol is combined with Pirlindole.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when rasagiline is combined with triflupromazine.


The risk or severity of adverse effects can be increased when rasagiline is combined with haloperidol.


The risk or severity of adverse effects can be increased when thiamylal is combined with zonisamide.


The risk or severity of adverse effects can be increased when nimesulide is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Etomidate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with quazepam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with prazepam.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when trandolapril is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when alprazolam is combined with thiamylal.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pargyline is combined with droxidopa.


The risk or severity of adverse effects can be increased when fenoprofen is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Icatibant is combined with equilin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nitrazepam.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with primidone.


The risk or severity of adverse effects can be increased when meperidine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when procarbazine is combined with pimozide.


The risk or severity of adverse effects can be increased when procarbazine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with loratadine.


The risk or severity of adverse effects can be increased when thioridazine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when cabergoline is combined with vincristine.


The risk or severity of adverse effects can be increased when pramipexole is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when cabergoline is combined with amoxapine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Efonidipine.


The risk or severity of adverse effects can be increased when clozapine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when cabergoline is combined with zafirlukast.


The risk or severity of adverse effects can be increased when tiapride is combined with clomipramine.


The risk or severity of adverse effects can be increased when procyclidine is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when sertraline is combined with MELPERONE.


The risk or severity of adverse effects can be increased when sertraline is combined with zotepine.


The risk or severity of adverse effects can be increased when triamterene is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when amoxapine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with furosemide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with tizanidine.


The risk or severity of adverse effects can be increased when enflurane is combined with Iloperidone.


The risk or severity of adverse effects can be increased when amoxapine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with irinotecan.


The risk or severity of adverse effects can be increased when LISURIDE is combined with methimazole.


The risk or severity of adverse effects can be increased when amoxapine is combined with clonazepam.


The risk or severity of adverse effects can be increased when amoxapine is combined with promethazine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with valsartan.


The risk or severity of adverse effects can be increased when Nabilone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when nimesulide is combined with lovastatin.


The risk or severity of adverse effects can be increased when nimesulide is combined with diflorasone.


The risk or severity of adverse effects can be increased when doxazosin is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when loxapine is combined with felbamate.


The risk or severity of adverse effects can be increased when codeine is combined with tiagabine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with felbamate.


The risk or severity of adverse effects can be increased when risperidone is combined with glutethimide.


The risk or severity of adverse effects can be increased when pancuronium is combined with levorphanol.


The risk or severity of adverse effects can be increased when azelastine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Halobetasol is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Normethadone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when docetaxel is combined with clozapine.


The risk or severity of adverse effects can be increased when docetaxel is combined with vinorelbine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with betamethasone.


The risk or severity of adverse effects can be increased when leflunomide is combined with diflorasone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Pramocaine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with atorvastatin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with etizolam.


The risk or severity of adverse effects can be increased when THYMOL is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with desipramine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when fenbufen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with lisinopril.


The risk or severity of adverse effects can be increased when Naftifine is combined with flunisolide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when oxycodone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when trimetrexate is combined with manidipine.


The risk or severity of adverse effects can be increased when propranolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Halazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with fosinopril.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with sotalol.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when timolol is combined with sotalol.


The risk or severity of adverse effects can be increased when aspirin is combined with formestane.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with testosterone.


The risk or severity of adverse effects can be increased when betamethasone is combined with memantine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with brimonidine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Nabilone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with baclofen.


The risk or severity of adverse effects can be increased when morniflumate is combined with suprofen.


The risk or severity of adverse effects can be increased when Asenapine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with cilazapril.


The risk or severity of adverse effects can be increased when Asenapine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when sulindac is combined with etodolac.


The risk or severity of adverse effects can be increased when ramipril is combined with bumetanide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with clonidine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when benazepril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when risperidone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Pramocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when diclofenac is combined with fenoprofen.


The risk or severity of adverse effects can be increased when isoflurane is combined with nitric oxide.


The risk or severity of adverse effects can be increased when isoflurane is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with cetirizine.


The risk or severity of adverse effects can be increased when isoflurane is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when zaleplon is combined with METAXALONE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with protriptyline.


The risk or severity of adverse effects can be increased when codeine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when prilocaine is combined with desipramine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with fexofenadine.


The risk or severity of adverse effects can be increased when prilocaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when codeine is combined with amisulpride.


The risk or severity of adverse effects can be increased when alprazolam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when oxybutynin is combined with codeine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with furazolidone.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when butorphanol is combined with halothane.


The risk or severity of adverse effects can be increased when carbamazepine is combined with butorphanol.


The risk or severity of adverse effects can be increased when tizanidine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when formestane is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Linagliptin is combined with enalapril.


The risk or severity of adverse effects can be increased when Amrinone is combined with simvastatin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nortriptyline is combined with ethosuximide.


The risk or severity of adverse effects can be increased when topiramate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Treprostinil is combined with niflumic acid.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when trimipramine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when zaleplon is combined with thiopental.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when diltiazem is combined with methazolamide.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when butorphanol is combined with desipramine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when meperidine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with brotizolam.


The risk or severity of adverse effects can be increased when trandolapril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when apomorphine is combined with Riociguat.


The risk or severity of adverse effects can be increased when protriptyline is combined with terbutaline.


The risk or severity of adverse effects can be increased when thiamylal is combined with venlafaxine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with prednisone.


The risk or severity of adverse effects can be increased when thiamylal is combined with clemastine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with antipyrine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with efavirenz.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Desloratadine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Telmisartan.


The risk or severity of adverse effects can be increased when ipratropium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when halothane is combined with Eprosartan.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with zaleplon.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when sulindac is combined with diflorasone.


The risk or severity of adverse effects can be increased when trandolapril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when trandolapril is combined with ketorolac.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chlormezanone.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with doxepin.


The risk or severity of adverse effects can be increased when methyldopa is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when spironolactone is combined with carvedilol.


The risk or severity of adverse effects can be increased when risperidone is combined with Etomidate.


The risk or severity of adverse effects can be increased when pergolide is combined with Tadalafil.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with carmustine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when bromazepam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when amcinonide is combined with ambenonium.


The risk or severity of adverse effects can be increased when midazolam is combined with Asenapine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when captopril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when methylphenidate is combined with Dothiepin.


The risk or severity of adverse effects can be increased when salicylamide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when etizolam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when butabarbital is combined with bromazepam.


The risk or severity of adverse effects can be increased when sertraline is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when butabarbital is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when nimesulide is combined with Tixocortol.


The risk or severity of adverse effects can be increased when glutethimide is combined with Olopatadine.


The risk or severity of adverse effects can be increased when desipramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Lofexidine is combined with thioridazine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when trandolapril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when betaxolol is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with glutethimide.


The risk or severity of adverse effects can be increased when bromazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when tizanidine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when bromazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when bromazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when butenafine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when meperidine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Trospium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with captopril.


The risk or severity of adverse effects can be increased when zotepine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with oxprenolol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when clozapine is combined with meprobamate.


The risk or severity of adverse effects can be increased when triprolidine is combined with duloxetine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with prazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with quazepam.


The risk or severity of adverse effects can be increased when procarbazine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when zopiclone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when maprotiline is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when secobarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with theobromine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Eletriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when proparacaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when doxepin is combined with citalopram.


The risk or severity of adverse effects can be increased when proparacaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when pergolide is combined with irbesartan.


The risk or severity of adverse effects can be increased when buspirone is combined with clonidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with lomustine.


The risk or severity of adverse effects can be increased when pergolide is combined with felodipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when isradipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sotalol is combined with metolazone.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with antipyrine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with flunarizine.


The risk or severity of adverse effects can be increased when glutethimide is combined with baclofen.


The risk or severity of adverse effects can be increased when epinephrine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with loteprednol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with suprofen.


The risk or severity of adverse effects can be increased when loxapine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when floctafenine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with midazolam.


The risk or severity of adverse effects can be increased when estazolam is combined with clomipramine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Salsalate is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with salicylamide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Salsalate is combined with Tixocortol.


The risk or severity of adverse effects can be increased when clomipramine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when isoproterenol is combined with nylidrin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when procaine is combined with felbamate.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with paramethasone.


The risk or severity of adverse effects can be increased when cabergoline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when selegiline is combined with clomipramine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Caspofungin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when bumetanide is combined with nifedipine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with resveratrol.


The risk or severity of adverse effects can be increased when isoflurane is combined with levorphanol.


The risk or severity of adverse effects can be increased when cerulenin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when estazolam is combined with prilocaine.


The risk or severity of adverse effects can be increased when sotalol is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with acebutolol.


The risk or severity of adverse effects can be increased when ramipril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with felbamate.


The risk or severity of adverse effects can be increased when estazolam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when Butethal is combined with prazepam.


The risk or severity of adverse effects can be increased when prazosin is combined with losartan.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Demecarium.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with clidinium.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Riociguat.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when trimipramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when azelastine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Nepafenac is combined with medrysone.


The risk or severity of adverse effects can be increased when propofol is combined with clidinium.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with triprolidine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with fenbufen.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with spironolactone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Carbetocin.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with trimipramine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with carvedilol.


The risk or severity of adverse effects can be increased when Tramadol is combined with butalbital.


The risk or severity of adverse effects can be increased when Torasemide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when nabumetone is combined with fenbufen.


The risk or severity of adverse effects can be increased when risperidone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Tramadol is combined with cabergoline.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when thioridazine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when estazolam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nifedipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when nicergoline is combined with methazolamide.


The risk or severity of adverse effects can be increased when diazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with estazolam.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with lovastatin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when mesalamine is combined with betamethasone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with protriptyline.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with bumetanide.


The risk or severity of adverse effects can be increased when Etomidate is combined with Butethal.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with quinapril.


The risk or severity of adverse effects can be increased when clonazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when reserpine is combined with doxazosin.


The risk or severity of adverse effects can be increased when ketamine is combined with butamben.


The risk or severity of adverse effects can be increased when Ramelteon is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when reserpine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when reserpine is combined with thiopental.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with nitrazepam.


The risk or severity of adverse effects can be increased when bromazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with flunarizine.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nimodipine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with epirizole.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when butamben is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when phentolamine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with triprolidine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with spironolactone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with doxepin.


The risk or severity of adverse effects can be increased when amisulpride is combined with loratadine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when triamcinolone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with dantrolene.


The risk or severity of adverse effects can be increased when tolnaftate is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Telmisartan is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with carvedilol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with estrone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Tapentadol is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with propranolol.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with clonidine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when propranolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with lidocaine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with propantheline.


The risk or severity of adverse effects can be increased when nalbuphine is combined with polythiazide.


The risk or severity of adverse effects can be increased when quinapril is combined with Salsalate.


The risk or severity of adverse effects can be increased when alprazolam is combined with risperidone.


The risk or severity of adverse effects can be increased when alprazolam is combined with meclizine.


The risk or severity of adverse effects can be increased when propofol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Halazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with proparacaine.


The risk or severity of adverse effects can be increased when perphenazine is combined with procaine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when perphenazine is combined with trimipramine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with isradipine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tizanidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when felbamate is combined with doxepin.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Aceprometazine.